Geneva University Hospitals (HUG) at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Geneva University Hospitals (HUG) takes part in 3 sessions at ESMO 2026 in Madrid. Its program spans melanoma and other skin tumours, endocrine and neuroendocrine tumours, and cancers of the stomach and gastroesophageal junction. Specific topics include emerging therapies for thyroid carcinoma and current debates over how to treat resectable and advanced gastric cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
Geneva University Hospitals (HUG) Geneva, Switzerland | |
Public university hospital group of Geneva, Switzerland, linked with the University of Geneva faculty of medicine. | Chair Fri Oct 23 16:15–17:45 Proffered paper: Melanoma and other skin tumours Melanoma & skin cancers Abstract Fri Oct 23 16:35–16:47 Invited Discussant 2071O and LBA54 Melanoma & skin cancers Chair Sat Oct 24 14:45–16:15 Emerging therapies in endocrine and neuroendocrine neoplasms Sarcoma, CNS, head & neck and rare cancers Talk Sat Oct 24 14:45–15:00 Thyroid carcinoma Sarcoma, CNS, head & neck and rare cancers Satellite Mon Oct 26 13:05–13:25 Plenary: The emerging standard: optimising clinical practice for resectable GC / GEJC Gastrointestinal cancers Satellite Mon Oct 26 13:25–13:30 Audience Q&A Gastrointestinal cancers Satellite Mon Oct 26 13:50–14:20 Satellite Mon Oct 26 14:20–14:25 Audience Q&A Gastrointestinal cancers |
Instantly find 20 buyers from Geneva University Hospitals (HUG)
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction